This ticker has not been starred yet ALT Altimmune, Inc.
Pharmaceutical Preparations
Book value per $ invested $ 0.36
Leverage 11.34%
Market Cap $ 342.3m
PE 0.00
Dividend Yield 0.00%
Profit $ -94.6m
Margin -144691.57%

Altimmune, Inc., a clinical-stage biopharmaceutical company, focuses on the development of intranasal vaccines, immunomodulatory therapies, and treatments for liver disease. The company is headquartered in Gaithersburg, Maryland.

Subscribe Now For Access - Only $1.99 Per Month